Polyherbal gel formulation with Solanum nigrum, Aloe vera, Psidium guajava and Moringa oleifera: A preclinical evaluation for accelerated wound healing in diabetic foot ulcers.
{"title":"Polyherbal gel formulation with <i>Solanum nigrum</i>, <i>Aloe vera, Psidium guajava</i> and <i>Moringa oleifera</i>: A preclinical evaluation for accelerated wound healing in diabetic foot ulcers.","authors":"Diksha Manhas, Udayabanu Malairaman","doi":"10.1177/08853282251374422","DOIUrl":null,"url":null,"abstract":"<p><p>A common and fatal consequence of diabetes, diabetic foot ulcers (DFU) are linked to an increased risk of mortality and amputation. The current study aimed to develop and evaluate a polyherbal gel formulation (PGF) employing hydro-alcoholic extracts of <i>Solanum nigrum</i> (fruits), <i>Aloe vera</i> (leaves), <i>Psidium guajava</i> (fruits), and <i>Moringa oleifera</i> (bark) at different concentrations for the efficient treatment and management of DFU. The anti-oxidant, anti-diabetic, anti-inflammatory, anti-bacterial, and wound healing activities of PGFs were investigated using a range of cell-based <i>in-vitro</i> assays and animal models. Each PGF exhibited a remarkable α-amylase inhibitory activity, with PGF 4 demonstrating the highest inhibition of α-amylase (IC50- 0.093 mg/mL). Fluorescent microscopy analysis revealed significant glucose uptake by McCoy fibroblast cells in the presence of PGFs. In addition to this, the PGFs exhibited notable anti-bacterial efficacy against a spectrum of tested pathogens. The administration of PGFs to McCoy cells displayed enhanced wound closure, with 86.04 % closure rate in presence of PGF 4 in scratch assay. <i>In-vivo</i> assessments encompassed the evaluation of PGFs efficacy in inducing caudal fin regeneration in Zebra fish, revealing PGF 3 and PGF 4 to be effective with a substantial 56.67% and 73.3% regeneration, respectively, after 8 days post-amputation. In a diabetic rat model, wherein circular wounds were inflicted, a 14 days regimen of topical PGF 4 application demonstrated enhanced efficacy compared to the standard Calendula cream (79%) in expediting diabetic wound closure. Collectively, these findings underscore the promising potential of PGF 4 for advance therapeutic approach in the management of DFUs.</p>","PeriodicalId":15138,"journal":{"name":"Journal of Biomaterials Applications","volume":" ","pages":"8853282251374422"},"PeriodicalIF":2.5000,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Biomaterials Applications","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1177/08853282251374422","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
A common and fatal consequence of diabetes, diabetic foot ulcers (DFU) are linked to an increased risk of mortality and amputation. The current study aimed to develop and evaluate a polyherbal gel formulation (PGF) employing hydro-alcoholic extracts of Solanum nigrum (fruits), Aloe vera (leaves), Psidium guajava (fruits), and Moringa oleifera (bark) at different concentrations for the efficient treatment and management of DFU. The anti-oxidant, anti-diabetic, anti-inflammatory, anti-bacterial, and wound healing activities of PGFs were investigated using a range of cell-based in-vitro assays and animal models. Each PGF exhibited a remarkable α-amylase inhibitory activity, with PGF 4 demonstrating the highest inhibition of α-amylase (IC50- 0.093 mg/mL). Fluorescent microscopy analysis revealed significant glucose uptake by McCoy fibroblast cells in the presence of PGFs. In addition to this, the PGFs exhibited notable anti-bacterial efficacy against a spectrum of tested pathogens. The administration of PGFs to McCoy cells displayed enhanced wound closure, with 86.04 % closure rate in presence of PGF 4 in scratch assay. In-vivo assessments encompassed the evaluation of PGFs efficacy in inducing caudal fin regeneration in Zebra fish, revealing PGF 3 and PGF 4 to be effective with a substantial 56.67% and 73.3% regeneration, respectively, after 8 days post-amputation. In a diabetic rat model, wherein circular wounds were inflicted, a 14 days regimen of topical PGF 4 application demonstrated enhanced efficacy compared to the standard Calendula cream (79%) in expediting diabetic wound closure. Collectively, these findings underscore the promising potential of PGF 4 for advance therapeutic approach in the management of DFUs.
期刊介绍:
The Journal of Biomaterials Applications is a fully peer reviewed international journal that publishes original research and review articles that emphasize the development, manufacture and clinical applications of biomaterials.
Peer-reviewed articles by biomedical specialists from around the world cover:
New developments in biomaterials, R&D, properties and performance, evaluation and applications
Applications in biomedical materials and devices - from sutures and wound dressings to biosensors and cardiovascular devices
Current findings in biological compatibility/incompatibility of biomaterials
The Journal of Biomaterials Applications publishes original articles that emphasize the development, manufacture and clinical applications of biomaterials. Biomaterials continue to be one of the most rapidly growing areas of research in plastics today and certainly one of the biggest technical challenges, since biomaterial performance is dependent on polymer compatibility with the aggressive biological environment. The Journal cuts across disciplines and focuses on medical research and topics that present the broadest view of practical applications of biomaterials in actual clinical use.
The Journal of Biomaterial Applications is devoted to new and emerging biomaterials technologies, particularly focusing on the many applications which are under development at industrial biomedical and polymer research facilities, as well as the ongoing activities in academic, medical and applied clinical uses of devices.